UMP Healthcare Holdings Limited

FY21 Annual Results Presentation 24 September 2021

PRESENTERS

Dr. SUN Yiu Kwong

Ms. Jacquen KWOK

Mr. Felix LEE

Mr. Danny HO

UMP Group Executive

UMP Group Executive

UMP Group Executive

UMP Group Chief Financial

Director, Chairman and CEO

Director, Managing Director

Director, President and CEO

Officer, SVP and CFO for

for Hong Kong & Macau

for Mainland China

UMP China

Performance Drivers

SUSTAINED PERFORMANCE GROWTH

WITH RECORD TURNOVER AND ADJUSTED EBITDA IN 2021

Approx.

Turnover

EBITDA

2021 +12% -14%

2020 -2% +197%

2019 +22% -21%

Adjusted EBITDA

Achievements

Solid sales and record

+30% adjusted EBITDA amidst challenging

environment

-12%

Resilient performance

in face of Covid

+30%

Strong turnover and

adjusted EBITDA growth

FY2021 Final Dividend HK2.80 cents and full year dividend HK3.80 cents

4

SUSTAINED PERFORMANCE GROWTH

WITH EXTENSIVE SERVICE POINTS AND BROAD CLIENT NETWORKS

Mainland China Hong Kong & Macau

AFFORDABLE

ACCESSIBILE

TRUSTED

1,076,682

1,038,317

1,100+

Patient Visits

Average Policy

Total Service Points

-16%

members serviced

- 4%

47,983

127,071

1,252

158

Patient interactions

New policy

GOLD Doctors

PPP Clinics

(incl. 17,010 virtual

members covered

(incl. 336 GOLD-C)

(73 physically

consultations)

constructed)

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

UMP Healthcare Holdings Ltd. published this content on 23 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2021 12:31:01 UTC.